田中（佐々木）玲奈 (Reina SASAKI-TANAKA) - マイポータル

基本情報

所属: 新潟大学大学院医歯学総合研究科消化器内科特任講師

学位: 博士（医学）(2016年3月千葉大学)

連絡先: reinasasakimed.niigata-u.ac.jp
ORCID iD: https://orcid.org/0000-0003-2681-0776
J-GLOBAL ID: 202101000916380120
researchmap会員ID: R000026884

外部リンク: https://www.med.niigata-u.ac.jp/in3/about/staff.html

研究分野

ライフサイエンス / 消化器内科学 /

論文

105

STRIDE sustained an overall survival benefit with safety profiles in unresectable hepatocellular carcinoma at 5-year follow-up

Tatsuo Kanda, Reina Sasaki-Tanaka, Hiroteru Kamimura, Kazunao Hayashi, Kenya Kamimura, Shuji Terai

Hepatobiliary Surgery and Nutrition 15(1) 17-17 2026年2月
Azathioprine Inhibits Hepatitis A Virus Replication In Vitro

Tatsuo Kanda, Reina Sasaki-Tanaka, Hiroyuki Abe, Takeshi Yokoo, Akira Sakamaki, Kazunao Hayashi, Hiroteru Kamimura, Kenya Kamimura, Ryota Masuzaki, Hirofumi Kogure …

Pathogens 2026年2月
Is higher body mass index correlated with worse clinical outcomes in acute liver failure?

Tatsuo Kanda, Reina Sasaki-Tanaka, Hiroteru Kamimura, Shuji Terai

World Journal of Clinical Cases 13(32) 2025年11月16日
Successful Retreatment of Glecaprevir-Pibrentasvir for Hepatitis C Virus Genotype 2a Infection in Patient Whose Cirrhosis Improved From Decompensation to Compensation After Sofosbuvir-Velpatasvir Therapy.

Tatsuo Kanda, Ryota Masuzaki, Naoki Matsumoto, Reina Sasaki-Tanaka, Hirofumi Kogure

Hepatology research : the official journal of the Japan Society of Hepatology 2025年9月27日
Zinc Acetate Inhibits Hepatitis A Virus Replication: Possible Treatment for Patients with Type A Acute-on-Chronic Liver Failure

Tatsuo Kanda, Reina Sasaki-Tanaka, Hiroyuki Abe, Takeshi Yokoo, Akira Sakamaki, Kazunao Hayashi, Hiroteru Kamimura, Atsunori Tsuchiya, Ryota Masuzaki, Hirofumi Kogure …

Pathogens 14(9) 882-882 2025年9月3日
Carbon-Ion Radiotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects: A Narrative Review

Reina Sasaki-Tanaka, Hiroyuki Abe, Tomoaki Yoshida, Yusuke Watanabe, Naruhiro Kimura, Takeshi Yokoo, Akira Sakamaki, Hiroteru Kamimura, Kenya Kamimura, Tatsuo Kanda …

Journal of Clinical Medicine 14(17) 6107-6107 2025年8月29日
Cholestasis in hepatitis E virus infection.

Tatsuo Kanda, Reina Sasaki-Tanaka, Takeshi Yokoo, Kazunao Hayashi, Hiroteru Kamimura, Atsunori Tsuchiya, Shuji Terai

World journal of hepatology 17(4) 99899-99899 2025年4月27日
Combination therapies with immune checkpoint inhibitor-based combination therapies for hepatocellular carcinoma with major vascular invasion

Tatsuo Kanda, Reina Sasaki-Tanaka, Shuji Terai

Hepatology International 2025年2月8日
Hepatitis B virus infection and its treatment in Eastern Ethiopia

Tatsuo Kanda, Reina Sasaki-Tanaka, Atsunori Tsuchiya, Shuji Terai

World Journal of Hepatology 17(1) 2025年1月27日
Inflammation of the liver, HCC development and HCC establishment

Tatsuo Kanda, Reina Sasaki-Tanaka, Shuji Terai

Hepatology International 2024年6月28日
Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection.

Tatsuo Kanda, Tian-Cheng Li, Masaharu Takahashi, Shigeo Nagashima, Putu Prathiwi Primadharsini, Satoshi Kunita, Reina Sasaki-Tanaka, Jun Inoue, Atsunori Tsuchiya, Shingo Nakamoto …

Hepatology research : the official journal of the Japan Society of Hepatology 2024年6月14日
Liver Diseases: From Bench to Bedside

Tatsuo Kanda, Reina Sasaki-Tanaka, Shuji Terai

International Journal of Molecular Sciences 25(10) 5454 2024年5月17日査読有り招待有り
Severe hepatitis E virus genotype 3b in a patient with alcohol‑associated liver disease: A case report.

Tatsuo Kanda, Shuhei Arima, Reina Sasaki-Tanaka, Mai Totsuka, Masayuki Honda, Ryota Masuzaki, Naoki Matsumoto, Masahiro Ogawa, Masaharu Takahashi, Hiroaki Okamoto …

Medicine international 4(3) 22-22 2024年
Elderly patient with unresectable advanced‑stage hepatocellular carcinoma who received atezolizumab plus bevacizumab and achieved a complete response: A case report.

Shuhei Arima, Tatsuo Kanda, Mai Totsuka, Masayuki Honda, Shini Kanezawa, Reina Sasaki-Tanaka, Naoki Matsumoto, Ryota Masuzaki, Hiroaki Yamagami, Masahiro Ogawa …

Medicine international 4(3) 23-23 2024年
Liver biopsy as a useful diagnostic tool for hepatic sarcoidosis: A case report.

Kenrei Uehara, Tatsuo Kanda, Shuhei Arima, Mai Totsuka, Masayuki Honda, Ryota Masuzaki, Reina Sasaki-Tanaka, Naoki Matsumoto, Masahiro Ogawa, Hirofumi Kogure

Medicine international 4(4) 38-38 2024年
Recent advances in hepatitis A virus research and clinical practice guidelines for hepatitis A virus infection in Japan.

Tatsuo Kanda, Reina Sasaki-Tanaka, Koji Ishii, Ryosuke Suzuki, Jun Inoue, Atsunori Tsuchiya, Shingo Nakamoto, Ryuzo Abe, Keiichi Fujiwara, Osamu Yokosuka …

Hepatology research : the official journal of the Japan Society of Hepatology 54(1) 4-23 2024年1月
Hepatitis E Virus Infection Caused Elevation of Alanine Aminotransferase Levels in a Patient with Chronic Hepatitis B and Choledocholithiasis

Rei Hirano, Tatsuo Kanda, Masayuki Honda, Shuhei Arima, Mai Totsuka, Ryota Masuzaki, Shini Kanezawa, Reina Sasaki-Tanaka, Naoki Matsumoto, Hiroaki Yamagami …

Reports 6(4) 55-55 2023年11月17日
Muscle Cramps in Outpatients with Liver Diseases in Tokyo, Japan

Tatsuo Kanda, Reina Sasaki-Tanaka, Naoki Matsumoto, Shuhei Arima, Shini Kanezawa, Masayuki Honda, Mai Totsuka, Tomotaka Ishii, Ryota Masuzaki, Masahiro Ogawa …

Medicina 59(9) 1506-1506 2023年8月22日
Masitinib Inhibits Hepatitis A Virus Replication

Reina Sasaki-Tanaka, Toshikatsu Shibata, Mitsuhiko Moriyama, Hirofumi Kogure, Asuka Hirai-Yuki, Hiroaki Okamoto, Tatsuo Kanda

International Journal of Molecular Sciences 24(11) 9708-9708 2023年6月3日
Molecular Mechanisms, Diagnosis and Treatments in Digestive Malignancy

Tatsuo Kanda, Ryota Masuzaki, Reina Sasaki-Tanaka, Hirofumi Kogure, Mitsuhiko Moriyama

International Journal of Molecular Sciences 24(7) 6471-6471 2023年3月30日

もっとみる

MISC

Assessment of serum hepatitis C virus RNA 24 weeks after the end of treatment using TaqMan PCR is more relevant than after 12 weeks for predicting sustained virological response by simeprevir-versus telaprevir-based triple therapy

Tatsuo Kanda, Shingo Nakamoto, Reina Sasaki, Yuki Haga, Masato Nakamura, Shin Yasui, Makoto Arai, Fumio Imazeki, Osamu Yokosuka

HEPATOLOGY 62 807A-807A 2015年10月
Assessment of serum hepatitis C virus RNA 24 weeks after the end of treatment using TaqMan PCR is more relevant than after 12 weeks for predicting sustained virological response by simeprevir-versus telaprevir-based triple therapy

Tatsuo Kanda, Shingo Nakamoto, Reina Sasaki, Yuki Haga, Masato Nakamura, Shin Yasui, Makoto Arai, Fumio Imazeki, Osamu Yokosuka

HEPATOLOGY 62 807A-807A 2015年10月
HCV NS5A blocks MG132-induced apoptosis in hepatocytes through the inhibition of NF-kappa B activation

Xia Jiang, Tatsuo Kanda, Shuang Wu, Yuki Haga, Reina Sasaki, Masato Nakamura, Shingo Nakamoto, Fumio Imazeki, Osamu Yokosuka

HEPATOLOGY 60 647A-647A 2014年

共同研究・競争的資金等の研究課題

肝炎の重症化に関与するマイクロRNAの検討

日本学術振興会科学研究費助成事業若手研究 2023年4月 - 2026年3月

田中玲奈

田中（佐々木）玲奈

基本情報

研究分野

論文

MISC

共同研究・競争的資金等の研究課題

メニュー

共著者の一覧